SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-075207
Filing Date
2013-10-11
Accepted
2013-10-10 20:53:28
Documents
4
Period of Report
2013-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-22126_18k.htm 8-K 38482
2 EX-9.1 a13-22126_1ex9d1.htm EX-9.1 216548
3 EX-99.1 a13-22126_1ex99d1.htm EX-99.1 17903
4 GRAPHIC g221261moi001.jpg GRAPHIC 1944
  Complete submission text file 0001104659-13-075207.txt   276951
Mailing Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046
Business Address 7015 ALBERT EINSTEIN DRIVE COLUMBIA MD 21046 443-545-1819
OSIRIS THERAPEUTICS, INC. (Filer) CIK: 0001360886 (see all company filings)

IRS No.: 710881115 | State of Incorp.: MD | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32966 | Film No.: 131146789
SIC: 2836 Biological Products, (No Diagnostic Substances)